Azelaic acid

Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azelaic acid?

Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azelaic acid

MeSH term MeSH ID Detail
Disease Resistance D060467 12 associated lipids
Pituitary ACTH Hypersecretion D047748 1 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Hyperpigmentation D017495 11 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Rosacea D012393 13 associated lipids
Rhinophyma D012224 1 associated lipids
Psoriasis D011565 47 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Pituitary Apoplexy D010899 1 associated lipids
Pain D010146 64 associated lipids
Melanosis D008548 4 associated lipids
Melanoma D008545 69 associated lipids
Leukemia D007938 74 associated lipids
Keratosis D007642 9 associated lipids
Inflammation D007249 119 associated lipids
Heart Failure D006333 36 associated lipids
Facial Dermatoses D005148 7 associated lipids
Erythema D004890 22 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Drug Eruptions D003875 30 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Alopecia Areata D000506 6 associated lipids
Acne Keloid D000153 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Per page 10 20 50 | Total 27

PubChem Associated disorders and diseases

What pathways are associated with Azelaic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azelaic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azelaic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azelaic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azelaic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azelaic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Azelaic acid

Download all related citations
Per page 10 20 50 100 | Total 511
Authors Title Published Journal PubMed Link
Del Rosso JQ The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. 2009 Cutis pmid:19746764
Panyosak A et al. Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles. 2009 Hum Exp Toxicol pmid:19755450
Jansen T et al. Steroid-induced periorificial dermatitis in children--clinical features and response to azelaic acid. 2010 Mar-Apr Pediatr Dermatol pmid:19804495
Elsaie ML and Choudhary S Updates on the pathophysiology and management of acne rosacea. 2009 Postgrad Med pmid:19820288
Ebanks JP et al. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. 2009 Int J Mol Sci pmid:19865532
Litvinov D et al. Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. 2010 Atherosclerosis pmid:19880116
Wu YH et al. Effects of Chinese herbal medicine combined with He-Ne laser on lipoperoxide and superoxide dismutase in chloasma patients. 2009 J Tradit Chin Med pmid:19894376
pmid:19907406
Fujitani K et al. Preparation of polycarboxylic acids by oxidative cleavage with oxygen / Co-Mn-Br system. 2009 J Oleo Sci pmid:19915320
Sobottka A and Lehmann P [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies]. 2009 Hautarzt pmid:19957073
pmid:20017486
Li N et al. Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. 2010 Int J Pharm pmid:20025951
Safoury OS et al. A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. 2009 Indian J Dermatol pmid:20049268
Smit N et al. The hunt for natural skin whitening agents. 2009 Int J Mol Sci pmid:20054473
Truman WM et al. Arabidopsis auxin mutants are compromised in systemic acquired resistance and exhibit aberrant accumulation of various indolic compounds. 2010 Plant Physiol. pmid:20081042
Bandyopadhyay D Topical treatment of melasma. 2009 Indian J Dermatol pmid:20101327
Scheinfeld N and Berk T A review of the diagnosis and treatment of rosacea. 2010 Postgrad Med pmid:20107297
Barabash R et al. [Nelson syndrome: a rare cause of generalized hyperpigmentation of the skin]. 2010 Jan-Feb Actas Dermosifiliogr pmid:20109395
pmid:20176393
Brinkworth RI et al. Inhibition of HIV-1 proteinase by non-peptide carboxylates. 1991 Biochem. Biophys. Res. Commun. pmid:2018518
pmid:20188958
Patwardhan N Conference Report: ACSICON 2008. 2009 J Cutan Aesthet Surg pmid:20300376
Niimura Y On the origin and evolution of vertebrate olfactory receptor genes: comparative genome analysis among 23 chordate species. 2009 Genome Biol Evol pmid:20333175
pmid:20347661
pmid:20387875
Choi YS et al. A study of the efficacy of cleansers for acne vulgaris. 2010 J Dermatolog Treat pmid:20394494
Pazoki-Toroudi H et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. 2010 J Dermatolog Treat pmid:20394495
Fluhr JW and Degitz K [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. 2010 J Dtsch Dermatol Ges pmid:20482689
pmid:20493336
pmid:20493337
Sand M et al. Cutaneous lesions of the nose. 2010 Head Face Med pmid:20525327
Chaouch S et al. Peroxisomal hydrogen peroxide is coupled to biotic defense responses by ISOCHORISMATE SYNTHASE1 in a daylength-related manner. 2010 Plant Physiol. pmid:20543092
Mastrofrancesco A et al. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation. 2010 Exp. Dermatol. pmid:20545756
Elewski BE et al. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. 2011 J Eur Acad Dermatol Venereol pmid:20586834
Hoye TR et al. Total synthesis of peloruside A through kinetic lactonization and relay ring-closing metathesis cyclization reactions. 2010 Angew. Chem. Int. Ed. Engl. pmid:20645374
Del Rosso JQ et al. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. 2010 J Drugs Dermatol pmid:20645521
Preisz K and Kárpáti S [Rosacea: pathogenesis, clinical forms and therapy]. 2010 Orv Hetil pmid:20650811
Chae K et al. A multifaceted study of stigma/style cysteine-rich adhesin (SCA)-like Arabidopsis lipid transfer proteins (LTPs) suggests diversified roles for these LTPs in plant growth and reproduction. 2010 J. Exp. Bot. pmid:20667964
Iraji F et al. Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial. 2010 J Drugs Dermatol pmid:20684146
Xia Y et al. The glabra1 mutation affects cuticle formation and plant responses to microbes. 2010 Plant Physiol. pmid:20699396
Davis EC and Callender VD Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. 2010 J Clin Aesthet Dermatol pmid:20725554
Del Rosso JQ The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. 2009 J Clin Aesthet Dermatol pmid:20729951
Nazzaro-Porro M et al. The depigmenting effect of azelaic acid. 1990 Arch Dermatol pmid:2073286
Yu JS and Kim AK Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells. 2010 J. Biomed. Sci. pmid:20804622
pmid:20815367
Jones DA Rosacea, reactive oxygen species, and azelaic Acid. 2009 J Clin Aesthet Dermatol pmid:20967185
Merkviladze N et al. The efficacy of topical drugs in treatment of noninflammatory acne vulgaris. 2010 Georgian Med News pmid:20972276
pmid:21038901
Ghosh S Chemical leukoderma: what's new on etiopathological and clinical aspects? 2010 Jul-Sep Indian J Dermatol pmid:21063518
Tacchino RM et al. Short-term infusion of azelaic acid vs intralipid in healthy subjects evaluated by indirect calorimetry. 1990 Mar-Apr JPEN J Parenter Enteral Nutr pmid:2112625
pmid:21147347
Schallreuter KU and Wood JW A possible mechanism of action for azelaic acid in the human epidermis. 1990 Arch. Dermatol. Res. pmid:2114832
Del Rosso JQ Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. 2010 Cutis pmid:21229827
McFalda WL and Roebuck HL Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report. 2011 J Clin Aesthet Dermatol pmid:21278898
Chagnaud JL et al. Monoclonal anti-conjugated azelaic acid antibody production: application to multiple sclerosis. 1990 Neuroreport pmid:2129868
May D et al. Clinical inquiries. What is the most effective treatment for acne rosacea? 2011 J Fam Pract pmid:21301648
Sun H et al. Complete genome sequence of Nocardiopsis dassonvillei type strain (IMRU 509). 2010 Stand Genomic Sci pmid:21304737
pmid:21315390
pmid:21343346
pmid:21348540
pmid:21396555
van Zuuren EJ et al. Interventions for rosacea. 2011 Cochrane Database Syst Rev pmid:21412882
Keri J and Shiman M An update on the management of acne vulgaris. 2009 Clin Cosmet Investig Dermatol pmid:21436973
Yu L et al. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry. 2011 J. Gastroenterol. Hepatol. pmid:21443661
Purdy S and de Berker D Acne vulgaris. 2011 BMJ Clin Evid pmid:21477388
Castellucci N et al. Formation of gels in the presence of metal ions. 2011 Amino Acids pmid:21487726
pmid:21492954
Angius AG et al. [Evaluation of the anti-comedo effect of azelaic acid using the technique of horny layer biopsy and scanning electron microscopy]. 1990 G Ital Dermatol Venereol pmid:2149715
Sato C et al. Cellulase applied to the leaves of sweet pepper (Capsicum annuum L. var. grossum) upregulates the production of salicylic and azelaic acids. 2011 Biosci. Biotechnol. Biochem. pmid:21512237
Manzano E et al. Study of the GC-MS determination of the palmitic-stearic acid ratio for the characterisation of drying oil in painting: La Encarnación by Alonso Cano as a case study. 2011 Talanta pmid:21530791
Abaffy T and Defazio AR The location of olfactory receptors within olfactory epithelium is independent of odorant volatility and solubility. 2011 BMC Res Notes pmid:21548958
Rathi SK Acne vulgaris treatment : the current scenario. 2011 Indian J Dermatol pmid:21572783
Zeng JP et al. 2,2'-(Heptane-1,7-di-yl)dibenz-imidazo-lium chloride nitrate monohydrate. 2009 Acta Crystallogr Sect E Struct Rep Online pmid:21582272
Pazoki-Toroudi H et al. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. 2011 Cutan Ocul Toxicol pmid:21612319
Kircik LH Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. 2011 J Drugs Dermatol pmid:21637899
Wheeland RG and Dhawan S Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. 2011 J Drugs Dermatol pmid:21637900
Whitney KM and Ditre CM Management strategies for acne vulgaris. 2011 Clin Cosmet Investig Dermatol pmid:21691566
pmid:21692773
pmid:21715785
Alsantali A Alopecia areata: a new treatment plan. 2011 Clin Cosmet Investig Dermatol pmid:21833161
Song F et al. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. 2011 BMJ pmid:21846695
Khanna N and Rasool S Facial melanoses: Indian perspective. 2011 Sep-Oct Indian J Dermatol Venereol Leprol pmid:21860153
Liu C et al. Heterogeneous reaction of suspended phosmet particles with NO3 radicals. 2011 J Phys Chem A pmid:21870875
Craythorne EE and Lawrence CM Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna. 2008 Clin Med Oncol pmid:21892331
Champigny MJ et al. Localization of DIR1 at the tissue, cellular and subcellular levels during Systemic Acquired Resistance in Arabidopsis using DIR1:GUS and DIR1:EGFP reporters. 2011 BMC Plant Biol. pmid:21896186
Parodi A et al. [Treatment of rosacea]. 2011 Ann Dermatol Venereol pmid:21907876
Schnopp C and Mempel M Acne vulgaris in children and adolescents. 2011 Minerva Pediatr. pmid:21909065
Del Rosso JQ and Bhatia N Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. 2011 Cutis pmid:21916272
Sheth VM and Pandya AG Melasma: a comprehensive update: part II. 2011 J. Am. Acad. Dermatol. pmid:21920242
pmid:21925368
pmid:21981383
Schauber J [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop]. 2011 Hautarzt pmid:22002717
Salimon J et al. Synthesis and physical properties of estolide ester using saturated Fatty Acid and ricinoleic Acid. 2011 J Autom Methods Manag Chem pmid:22007150
pmid:22054568
pmid:22103435
Li N et al. Effect of ionization and vehicle on skin absorption and penetration of azelaic acid. 2012 Drug Dev Ind Pharm pmid:22111946
Staroverov SA et al. Biodynamic parameters of micellar diminazene in sheep erythrocytes and blood plasma. 2011 J. Vet. Sci. pmid:22122895
Farshi S Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. 2011 J Cosmet Dermatol pmid:22151936
Karavelidis V et al. Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. 2011 Int J Nanomedicine pmid:22162659
Chudasama A et al. Investigation of microemulsion system for transdermal delivery of itraconazole. 2011 J Adv Pharm Technol Res pmid:22171289